XBiotech, Inc. (XBIT)
2.18
+0.03
(+1.40%)
USD |
NASDAQ |
Sep 29, 16:00
2.17
-0.01
(-0.46%)
Pre-Market: 20:00
XBiotech Price : 2.18 for Sept. 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 29, 2026 | 2.13 | 2.18 | 2.13 | 2.18 | 9549.00 |
| Sep 28, 2026 | 2.16 | 2.19 | 2.15 | 2.15 | 41689.00 |
| Sep 25, 2026 | 2.156 | 2.17 | 2.15 | 2.17 | 10829.00 |
| Sep 24, 2026 | 2.17 | 2.19 | 2.16 | 2.16 | 24001.00 |
| Sep 23, 2026 | 2.19 | 2.20 | 2.17 | 2.18 | 40037.00 |
| Sep 22, 2026 | 2.21 | 2.21 | 2.18 | 2.18 | 9100.00 |
| Sep 21, 2026 | 2.19 | 2.20 | 2.17 | 2.18 | 31839.00 |
| Sep 18, 2026 | 2.20 | 2.22 | 2.16 | 2.19 | 66092.00 |
| Sep 17, 2026 | 2.17 | 2.18 | 2.14 | 2.18 | 32119.00 |
| Sep 16, 2026 | 2.19 | 2.22 | 2.15 | 2.15 | 49067.00 |
| Sep 15, 2026 | 2.17 | 2.20 | 2.16 | 2.195 | 18231.00 |
| Sep 14, 2026 | 2.20 | 2.200 | 2.17 | 2.17 | 21883.00 |
| Sep 11, 2026 | 2.19 | 2.21 | 2.18 | 2.19 | 31325.00 |
| Sep 10, 2026 | 2.17 | 2.18 | 2.15 | 2.17 | 20270.00 |
| Sep 09, 2026 | 2.19 | 2.27 | 2.15 | 2.18 | 23958.00 |
| Sep 08, 2026 | 2.20 | 2.21 | 2.18 | 2.18 | 45362.00 |
| Sep 04, 2026 | 2.20 | 2.25 | 2.19 | 2.20 | 118606.0 |
| Sep 03, 2026 | 2.20 | 2.22 | 2.19 | 2.20 | 136190.0 |
| Sep 02, 2026 | 2.22 | 2.22 | 2.19 | 2.19 | 109028.0 |
| Sep 01, 2026 | 2.29 | 2.309 | 2.19 | 2.22 | 221171.0 |
| Aug 31, 2026 | 2.26 | 2.31 | 2.25 | 2.30 | 23052.00 |
| Aug 28, 2026 | 2.32 | 2.32 | 2.26 | 2.27 | 7073.00 |
| Aug 27, 2026 | 2.28 | 2.33 | 2.26 | 2.30 | 32783.00 |
| Aug 26, 2026 | 2.30 | 2.32 | 2.29 | 2.31 | 21900.00 |
| Aug 25, 2026 | 2.30 | 2.32 | 2.23 | 2.30 | 52245.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.22 |
| Alnylam Pharmaceuticals, Inc. | 254.07 |
| Anika Therapeutics, Inc. | 19.94 |
| Savara, Inc. | 5.08 |
| Vericel Corp. | 40.61 |
Price Related Metrics
| PEG Ratio | -0.0244 |
| Price to Book Value | 0.5174 |
| Earnings Yield | -67.91% |
| Market Cap | 66.46M |
| PEGY Ratio | -0.0244 |